Myocardial blood flow under general anaesthesia with sevoflurane in type 2 diabetic patients: A pilot study

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Bulte, Carolien S E ^a   van den Brom, Charissa E ^a   Loer, Stephan A ^a   Boer, Christa ^a   Bouwman, R A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anaesthesia; Hyperaemia; Myocardial blood flow; Type 2 diabetes mellitus

Indexed keywords

ADENOSINE; EXENDIN 4; GLICLAZIDE; GLIMEPIRIDE; HEMOGLOBIN A1C; LIRAGLUTIDE; METFORMIN; PIOGLITAZONE; SEVOFLURANE;

ADRENERGIC STIMULATION; ARTICLE; CLINICAL ARTICLE; COLD PRESSOR TEST; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; CORONARY VASCULAR RESISTANCE; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; GENERAL ANESTHESIA; HEART MUSCLE BLOOD FLOW; HEART RATE; HEART RATE VARIABILITY; HUMAN; HYPEREMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PILOT STUDY; SYSTOLIC BLOOD PRESSURE; VASCULAR ENDOTHELIUM; VASODILATATION;

ADULT; AGED; ANESTHESIA, GENERAL; BLOOD FLOW VELOCITY; CORONARY CIRCULATION; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; METHYL ETHERS; MIDDLE AGED; PILOT PROJECTS; VASODILATION;

EID: 84899585334     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-13-62     Document Type: Article

References (41)

1. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979, 241:2035-2038. 10.1001/jama.1979.03290450033020, 430798.
2. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Tarkington LG, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007, 116:e418-e499. 10.1161/CIRCULATIONAHA.107.185699, 17901357.
3. Valenta I, Dilsizian V, Quercioli A, Schelbert HR, Schindler TH. The Influence of Insulin Resistance, Obesity, and Diabetes Mellitus on Vascular Tone and Myocardial Blood Flow. Curr Cardiol Rep 2011, 14:217-225.
4. Setty S, Sun W, Martinez R, Downey HF, Tune JD. Alpha-adrenoceptor-mediated coronary vasoconstriction is augmented during exercise in experimental diabetes mellitus. J Appl Physiol 2004, 97:431-438. 10.1152/japplphysiol.01122.2003, 14978008.
5. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000, 87:840-844. 10.1161/01.RES.87.10.840, 11073878.
6. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, Munzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 2001, 88:E14-E22. 10.1161/01.RES.88.2.e14, 11157681.
7. Eringa EC, Serne EH, Meijer RI, Schalkwijk CG, Houben AJHM, Stehouwer CDA, Smulders YM, van Hinsbergh VWM. Endothelial dysfunction in (pre)diabetes: characteristics, causative mechanisms and pathogenic role in type 2 diabetes. Rev Endocr Metab Disord 2013, 14:39-48. 10.1007/s11154-013-9239-7, 23417760.
8. Prior JO, Quiñones MJ, Hernandez-Pampaloni M, Facta AD, Schindler TH, Sayre JW, Hsueh WA, Schelbert HR. Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus. Circulation 2005, 111:2291-2298. 10.1161/01.CIR.0000164232.62768.51, 15851590.
9. Di Carli MF, Bianco-Batlles D, Landa ME, Kazmers A, Groehn H, Muzik O, Grunberger G. Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation 1999, 100:813-819. 10.1161/01.CIR.100.8.813, 10458716.
10. Di Carli MF, Janisse J, Grunberger G, Ager J. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 2003, 41:1387-1393. 10.1016/S0735-1097(03)00166-9, 12706936.
11. Bernard JM, Wouters PF, Doursout MF, Florence B, Chelly JE, Merin RG. Effects of sevoflurane and isoflurane on cardiac and coronary dynamics in chronically instrumented dogs. Anesthesiology 1990, 72:659-662. 10.1097/00000542-199004000-00014, 2321783.
12. Crystal GJ, Zhou X, Gurevicius J, Czinn EA, Salem MR, Alam S, Piotrowski A, Hu G. Direct coronary vasomotor effects of sevoflurane and desflurane in in situ canine hearts. Anesthesiology 2000, 92:1103-1113. 10.1097/00000542-200004000-00029, 10754631.
13. Conzen PF, Vollmar B, Habazettl H, Frink EJ, Peter K, Messmer K. Systemic and regional hemodynamics of isoflurane and sevoflurane in rats. Anesth Analg 1992, 74:79-88.
14. Hirano M, Fujigaki T, Shibata O, Sumikawa K. A comparison of coronary hemodynamics during isoflurane and sevoflurane anesthesia in dogs. Anesth Analg 1995, 80:651-656.
15. Manohar M, Parks CM. Porcine systemic and regional organ blood flow during 1.0 and 1.5 minimum alveolar concentrations of sevoflurane anesthesia without and with 50% nitrous oxide. J Pharmacol Exp Ther 1984, 231:640-648.
16. Larach DR, Schuler HG. Direct vasodilation by sevoflurane, isoflurane, and halothane alters coronary flow reserve in the isolated rat heart. Anesthesiology 1991, 75:268-278. 10.1097/00000542-199108000-00015, 1859014.
17. Bulte CSE, Slikkerveer J, Kamp O, Heymans MW, Loer SA, de Marchi SF, Vogel R, Boer C, Bouwman RA. General anesthesia with sevoflurane decreases myocardial blood volume and hyperemic blood flow in healthy humans. Anesth Analg 2013, 116:767-774. 10.1213/ANE.0b013e31827e4e41, 23385053.
18. Bulte CSE, Slikkerveer J, Meijer RI, Gort D, Kamp O, Loer SA, de Marchi SF, Vogel R, Boer C, Bouwman RA. Contrast-enhanced ultrasound for myocardial perfusion imaging. Anesth Analg 2012, 114:938-945. 10.1213/ANE.0b013e318248e261, 22366851.
19. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation 2007, 115:387-397. 10.1161/CIRCULATIONAHA.106.634949, 17242296.
20. Vogel R, Indermühle A, Reinhardt J, Meier P, Siegrist PT, Namdar M, Kaufmann PA, Seiler C. The quantification of absolute myocardial perfusion in humans by contrast echocardiography: algorithm and validation. J Am Coll Cardiol 2005, 45:754-762. 10.1016/j.jacc.2004.11.044, 15734622.
21. Madonna R, De Caterina R. Cellular and molecular mechanisms of vascular injury in diabetes-part I: pathways of vascular disease in diabetes. Vascul Pharmacol 2011, 54:68-74. 10.1016/j.vph.2011.03.005, 21453786.
22. Picchi A, Limbruno U, Focardi M, Cortese B, Micheli A, Boschi L, Severi S, De Caterina R. Increased basal coronary blood flow as a cause of reduced coronary flow reserve in diabetic patients. Am J Physiol Heart Circ Physiol 2011, 301:H2279-H2284. 10.1152/ajpheart.00615.2011, 21984541.
23. Cosyns B, Droogmans S, Hernot S, Degaillier C, Garbar C, Weytjens C, Roosens B, Schoors D, Lahoutte T, Franken PR, Van Camp G. Effect of streptozotocin-induced diabetes on myocardial blood flow reserve assessed by myocardial contrast echocardiography in rats. Cardiovasc Diabetol 2008, 7:26. 10.1186/1475-2840-7-26, 2546381, 18764943.
24. Akata T, Izumi K, Nakashima M. The action of sevoflurane on vascular smooth muscle of isolated mesenteric resistance arteries (part 2): mechanisms of endothelium-independent vasorelaxation. Anesthesiology 2000, 92:1441-1453. 10.1097/00000542-200005000-00035, 10781291.
25. Di Carli MF, Tobes MC, Mangner T, Levine AB, Muzik O, Chakroborty P, Levine TB. Effects of cardiac sympathetic innervation on coronary blood flow. N Engl J Med 1997, 336:1208-1215. 10.1056/NEJM199704243361703, 9110908.
26. van den Brom CE, Bulte CS, Loer SA, Bouwman RA, Boer C. Diabetes, perioperative ischaemia and volatile anaesthetics: consequences of derangements in myocardial substrate metabolism. Cardiovasc Diabetol 2013, 12:42. 10.1186/1475-2840-12-42, 3599199, 23452502.
27. Zhu M, Chen J, Jiang H, Miao C. Propofol protects against high glucose-induced endothelial adhesion molecules expression in human umbilical vein endothelial cells. Cardiovasc Diabetol 2013, 12:13. 10.1186/1475-2840-12-13, 3579710, 23311470.
28. Xu W-Y, Wang N, Xu H-T, Yuan H-B, Sun H-J, Dun C-L, Zhou S-Q, Zou Z, Shi X-Y. Effects of sevoflurane and propofol on right ventricular function and pulmonary circulation in patients undergone esophagectomy. Int J Clin Exp Pathol 2014, 7:272-279. 3885482, 24427348.
29. El Messaoudi S, Rongen GA, de Boer RA, Riksen NP. The cardioprotective effects of metformin. Curr Opin Lipidol 2011, 22:445-453. 10.1097/MOL.0b013e32834ae1a7, 21897229.
30. Elmadhun NY, Lassaletta AD, Chu LM, Sellke FW. Metformin alters the insulin signaling pathway in ischemic cardiac tissue in a swine model of metabolic syndrome. J Thorac Cardiovasc Surg 2013, 145:258-265. discussion 265-6, 10.1016/j.jtcvs.2012.09.028, 3525723, 23083540.
31. Jadhav S, Ferrell W, Greer IA, Petrie JR, Cobbe SM, Sattar N. Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 2006, 48:956-963. 10.1016/j.jacc.2006.04.088, 16949486.
32. Schindler TH, Facta AD, Prior JO, Cadenas J, Hsueh WA, Quinones MJ, Schelbert HR. Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes. Heart 2007, 93:345-349. 10.1136/hrt.2006.094128, 1861464, 16940388.
33. Maruyama I, Tomiyama Y, Maruyama K, Ojima K, Kobayashi K, Kobayashi M, Yamazaki Y, Kojima M, Shibata N. Effects of mitiglinide and sulfonylureas in isolated canine coronary arteries and perfused rat hearts. Eur J Pharmacol 2006, 531:194-200. 10.1016/j.ejphar.2005.11.060, 16443212.
34. Legtenberg RJ, Houston RJF, Heerschap A, Oeseburg B, Smits P. Glibenclamide attenuates ischemia-induced acidosis and loss of cardiac function in rats. Eur J Pharmacol 2002, 434:35-42. 10.1016/S0014-2999(01)01483-2, 11755163.
35. Pop-Busui R, Oral E, Raffel D, Byun J, Bajirovic V, Vivekanandan-Giri A, Kellogg A, Pennathur S, Stevens MJ. Impact of rosiglitazone and glyburide on nitrosative stress and myocardial blood flow regulation in type 2 diabetes mellitus. Metab Clin Exp 2009, 58:989-994. 10.1016/j.metabol.2009.02.020, 19394661.
36. Gejl M, Søndergaard HM, Stecher C, Bibby BM, Møller N, Bøtker HE, Hansen SB, Gjedde A, Rungby J, Brock B. Exenatide alters myocardial glucose transport and uptake depending on insulin resistance and increases myocardial blood flow in patients with type 2 diabetes. J Clin Endocrinol Metab 2012, 97:E1165-E1169. 10.1210/jc.2011-3456, 22544917.
37. McMahon GT, Plutzky J, Daher E, Bhattacharyya T, Grunberger G, DiCarli MF. Effect of a peroxisome proliferator-activated receptor-gamma agonist on myocardial blood flow in type 2 diabetes. Diabetes Care 2005, 28:1145-1150. 10.2337/diacare.28.5.1145, 15855580.
38. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 1994, 94:2511-2515. 10.1172/JCI117621, 330085, 7989610.
39. Georgescu A, Popov D, Constantin A, Nemecz M, Alexandru N, Cochior D, Tudor A. Dysfunction of human subcutaneous fat arterioles in obesity alone or obesity associated with Type 2 diabetes. Clin Sci 2011, 120:463-472. 10.1042/CS20100355, 20979575.
40. de Boer MP, Meijer RI, Newman J, Stehouwer CDA, Eringa EC, Smulders YM, Serne EH. Insulin-induced changes in microvascular vasomotion and capillary recruitment are associated in humans. Microcirculation In press.
41. Wang T-D, Chen W-J, Cheng W-C, Lin J-W, Chen M-F, Lee Y-T. Relation of improvement in endothelium-dependent flow-mediated vasodilation after rosiglitazone to changes in asymmetric dimethylarginine, endothelin-1, and C-reactive protein in nondiabetic patients with the metabolic syndrome. Am J Cardiol 2006, 98:1057-1062. 10.1016/j.amjcard.2006.05.027, 17027571.